SCHEMBL6975896

SCHEMBL6975896

O=C(N[C@H]1CCN(C(=O)c2cc(Cl)nc3ccccc23)C1)[C@@H]1CCCCN1c1nc2ccccc2o1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 6/20 0.47
HCRTR2 O43614 6/20 0.47
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 2/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 1/20 0.45
ELANE P08246 2/20 0.41
RAB9A P51151 1/20 0.40
PTGES O14684 3/20 0.39
PTGS2 P35354 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6973405 0.90 HCRTR1 (0.52) HCRTR1HCRTR2GAASMN1; SMN2LMNA
SCHEMBL6979417 0.89 KDM4E (0.50) HCRTR1HCRTR2SMN1; SMN2LMNATSHR
SCHEMBL6965850 0.83 HCRTR1 (0.50) HCRTR1HCRTR2SMN1; SMN2LMNATSHR
SCHEMBL6975651 0.81 RAB9A (0.47) HCRTR1HCRTR2GAASMN1; SMN2LMNA
SCHEMBL6972771 0.81 SMN1; SMN2 (0.48) HCRTR1HCRTR2SMN1; SMN2LMNATSHR
SCHEMBL7680423 0.81 LMNA (0.58) HCRTR1HCRTR2SMN1; SMN2LMNATSHR
SCHEMBL6968264 0.79 OPRK1 (0.56) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6978779 0.79 OPRK1 (0.56) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6975687 0.78 LMNA (0.43) HCRTR1HCRTR2SMN1; SMN2LMNATSHR
SCHEMBL6966984 0.77 LMNA (0.50) HCRTR1HCRTR2KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP claimed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US claimed
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed